Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Hospira Inc., priced at $0.7201 per ML under NDC 00409330803. Its NADAC has been published 565 times since Nov 28, 2013.
The Low Outlier badge above means this manufacturer's average price in the ACETYLCYSTEINE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Hospira Inc.NDC
00409330803
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL; RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA074037On Market Since
6/1/2005
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 565 times since Nov 28, 2013, and over the history we have for it it has risen 128.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7201 per ML |
|---|---|
| All-time high | $0.7751 (Aug 14, 2024) |
| All-time low | $0.2303 (Feb 19, 2014) |
| 52-week high | $0.7267 |
| 52-week low | $0.5451 |
| Median price | $0.3332 |
| Average price | $0.3986 |
| Largest weekly change | +108.4% (Apr 17, 2024) |
| Weeks tracked | 565 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Hospira Inc., is $0.7201 per ML (NDC 00409330803), effective Jun 24, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 128.4%. It has been tracked across 565 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since Nov 28, 2013, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $0.2303 (Feb 19, 2014) to a high of $0.7751 (Aug 14, 2024), with a median of $0.3332 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), but none are currently priced below it.
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 00409330803) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification